Home » FDA Approves Generic Version of Purdue’s Dilaudid Drug
FDA Approves Generic Version of Purdue’s Dilaudid Drug
Lannett has received FDA approval for its
generic version of Purdue Pharmaceuticals’ Dilaudid, a pain treatment. The FDA approved the company’s
hydromorphone HCl tablets in 2-, 4- and 8-mg strengths, Lannett says. Only one other supplier has all three hydromorphone dosage strengths for which Lannett
received approval, the company said.
Generic Line
Generic Line
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May